CLEVELAND, Ohio — Cuyahoga County commissioners have released a development agreement (pdf) for Cleveland’s medical mart and convention center – a critical step in pushing ahead on the long-awaited project.
Officials from Merchandise Mart Properties Inc., which would run the facility, will likely sign the agreement Thursday or Friday, MMPI spokeswoman Sophia Weiss said. The company won’t discuss the pact they sign it, Weiss said.
County commissioners are expected to approve the document at their meeting next week.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The signatures will finally signal a major step forward in the discussions to develop the medical mart, which hopes to be a destination resource for medical goods and health-care conventions.
Its release is also an important step in openness. The release of the document a week ahead of its approval comes only after negotiations and the threat of lawsuit by The Plain Dealer – a symbol of the public frustration with a process many have seen as too private despite the hundreds of millions in public tax dollars set aside to fund the project.
Some public officials, though, have complained of excessive and lascivious scrutiny on the project, which is essentially the lone massive economic development project left in the city as the economy has forced others to shut down.
The next major hurdle after the development agreement is land acquisition. The City of Cleveland owns the bulk of the land planned for the medical mart and convention center. Cleveland Mayor Frank Jackson has pledged to get a fair price.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
